Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | 0.00% | +10.27% | +27.52% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.52% | 781M | |
+7.93% | 115B | |
+12.98% | 107B | |
-12.99% | 22.31B | |
-3.99% | 21.6B | |
-6.50% | 18.23B | |
-39.93% | 17.62B | |
+7.04% | 14.26B | |
+32.60% | 12.37B | |
-28.37% | 8.28B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences Appoints Ken Rhodes as Senior Vice President, Therapeutics Discovery